EPIGENOME-WIDE PERIPHERAL BLOOD DNA METHYLATION PROFILES ACCURATELY PREDICT ENDOSCOPIC- AND CLINICAL RESPONSE AND REMAIN HIGHLY STABLE DURING INDUCTION AND MAINTENANCE TREATMENT WITH ADALIMUMAB, VEDOLIZUMAB AND USTEKINUMAB IN CROHN'S DISEASE PATIENTS
Joustra V., Yim AYL., Hageman I., Levin E., Noble A., Chapman T., McGregor CG., Adams A., Satsangi JJ., De Jonge WJ., Henneman P., D'Haens G.